Publications by authors named "Blake Gilks"

100Publications

Primary mucinous ovarian neoplasms rarely exhibit a germ cell histogenesis.

Histopathology 2020 Nov 5. Epub 2020 Nov 5.

Department of Pathology, Vancouver General Hospital, University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.14297DOI Listing
November 2020

Whole proteome analysis of mesonephric-derived cancers describes new potential biomarkers.

Hum Pathol 2020 Oct 26. Epub 2020 Oct 26.

Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, V6T 2B5, Canada; Genetic Pathology Evaluation Centre, Vancouver General Hospital, Vancouver, BC, V6H 3Z6, Canada; Department of Anatomical Pathology, Vancouver General Hospital, Vancouver, BC, V5Z 1M9, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2020.10.005DOI Listing
October 2020

Comparison of p53 immunohistochemical staining in differentiated vulvar intraepithelial neoplasia (dVIN) with that in inflammatory dermatoses and benign squamous lesions in the vulva.

Histopathology 2020 Aug 16. Epub 2020 Aug 16.

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.14238DOI Listing
August 2020

Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).

Authors:
Aline Talhouk Joshy George Chen Wang Timothy Budden Tuan Zea Tan Derek S Chiu Stefan Kommoss Huei San Leong Stephanie Chen Maria P Intermaggio Blake Gilks Tayyebeh M Nazeran Mila Volchek Wafaa Elatre Rex C Bentley Janine Senz Amy Lum Veronica Chow Hanwei Sudderuddin Robertson Mackenzie Samuel C Y Leong Geyi Liu Dustin Johnson Billy Chen Aocs Group Jennifer Alsop Susana N Banerjee Sabine Behrens Clara Bodelon Alison H Brand Louise Brinton Michael E Carney Yoke-Eng Chiew Kara L Cushing-Haugen Cezary Cybulski Darren Ennis Sian Fereday Renée T Fortner Jesús García-Donas Aleksandra Gentry-Maharaj Rosalind Glasspool Teodora Goranova Casey S Greene Paul Haluska Holly R Harris Joy Hendley Brenda Y Hernandez Esther Herpel Mercedes Jimenez-Linan Chloe Karpinskyj Scott H Kaufmann Gary L Keeney Catherine J Kennedy Martin Köbel Jennifer M Koziak Melissa C Larson Jenny Lester Liz-Anne Lewsley Jolanta Lissowska Jan Lubiński Hugh Luk Geoff Macintyre Sven Mahner Iain A McNeish Janusz Menkiszak Nikilyn Nevins Ana Osorio Oleg Oszurek José Palacios Samantha Hinsley Celeste L Pearce Malcolm C Pike Anna M Piskorz Isabelle Ray-Coquard Valerie Rhenius Cristina Rodriguez-Antona Raghwa Sharma Mark E Sherman Dilrini De Silva Naveena Singh Peter Sinn Dennis Slamon Honglin Song Helen Steed Euan A Stronach Pamela J Thompson Aleksandra Tołoczko Britton Trabert Nadia Traficante Chiu-Chen Tseng Martin Widschwendter Lynne R Wilkens Stacey J Winham Boris Winterhoff Alicia Beeghly-Fadiel Javier Benitez Andrew Berchuck James D Brenton Robert Brown Jenny Chang-Claude Georgia Chenevix-Trench Anna deFazio Peter A Fasching María J García Simon A Gayther Marc T Goodman Jacek Gronwald Michelle J Henderson Beth Y Karlan Linda E Kelemen Usha Menon Sandra Orsulic Paul D P Pharoah Nicolas Wentzensen Anna H Wu Joellen M Schildkraut Mary Anne Rossing Gottfried E Konecny David G Huntsman Ruby Yun-Ju Huang Ellen L Goode Susan J Ramus Jennifer A Doherty David D Bowtell Michael S Anglesio

Clin Cancer Res 2020 Oct 17;26(20):5411-5423. Epub 2020 Jun 17.

British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-20-0103DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572656PMC
October 2020

Mismatch repair deficiency and prognostic significance in patients with low-risk endometrioid endometrial cancers.

Int J Gynecol Cancer 2020 06 30;30(6):783-788. Epub 2020 Apr 30.

Division Gynecology Oncology, Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ijgc-2019-000910DOI Listing
June 2020

Molecular subtypes of clear cell carcinoma of the endometrium: Opportunities for prognostic and predictive stratification.

Gynecol Oncol 2020 Jul 21;158(1):3-11. Epub 2020 Apr 21.

Department of Obstetrics and Gynecology, Division of Gynecology Oncology, University of British Columbia, Vancouver, BC, Canada; BC Cancer Agency, Vancouver, BC, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2020.04.043DOI Listing
July 2020

Interlaboratory Concordance of ProMisE Molecular Classification of Endometrial Carcinoma Based on Endometrial Biopsy Specimens.

Int J Gynecol Pathol 2020 Nov;39(6):537-545

Department of Laboratory Medicine, Trillium Health Partners, Mississauga (A.P.) Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto (A.P., V.D.V., B.C.) Department of Anatomical Pathology, Laboratory Medicine Program, University Health Network (V.D.V., B.C.), Toronto, Ontario Clinical Research Support Unit, BC Children's Hospital Research Institute (B.K.) Department of Pathology and Laboratory Medicine (E.F.T., C.B.G.) Department of Gynecologic Oncology (J.N.M.), University of British Columbia Vancouver, British Columbia University of Calgary, Pathology and Laboratory Science, Calgary, Alberta (M.K.), Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000654DOI Listing
November 2020

Hormone receptor expression and outcomes in low-grade serous ovarian carcinoma.

Gynecol Oncol 2020 04 15;157(1):12-20. Epub 2020 Jan 15.

Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.11.029DOI Listing
April 2020

The most important discoveries of the past 50 years in gynaecological pathology.

Histopathology 2020 Jan;76(1):6-10

Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13992DOI Listing
January 2020

The changing landscape of gynaecological pathology: WHO 2020 and beyond.

Histopathology 2020 01;76(1):2-5

Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.14035DOI Listing
January 2020

Vulval squamous cell carcinoma and its precursors.

Histopathology 2020 Jan;76(1):128-138

Vancouver General Hospital, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13989DOI Listing
January 2020

Interpretation of somatic POLE mutations in endometrial carcinoma.

J Pathol 2020 03 29;250(3):323-335. Epub 2020 Jan 29.

Department of Pathology and Laboratory Medicine, University of British Columbia and Vancouver General Hospital, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.5372DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065171PMC
March 2020

p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies.

J Pathol 2020 03 29;250(3):336-345. Epub 2020 Jan 29.

Department of Pathology, University of Calgary, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.5375DOI Listing
March 2020

Performance Characteristics of Endometrial Sampling in Diagnosis of Endometrial Carcinoma.

Int J Gynecol Pathol 2020 Jan;39(1):19-25

Department of Pathology and Laboratory Medicine, Vancouver General Hospital and University of British Columbia, Vancouver, British Columbia (C.T., H.B., P.B.C., C.B.G.) Department of Laboratory Medicine and Pathobiology, University of Toronto (A.P.) Department of Laboratory Medicine Trillium Health Partners (A.P.) Department of Pathology, Health Sciences Center and University of Manitoba, Winnipeg, Manitoba (N.A.), Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000569DOI Listing
January 2020

Association of human papilloma virus status and response to radiotherapy in vulvar squamous cell carcinoma.

Int J Gynecol Cancer 2020 01 25;30(1):100-106. Epub 2019 Nov 25.

Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ijgc-2019-000793DOI Listing
January 2020

Diagnostic Variation in p53 Usage for Endometrial Carcinoma Diagnosis: Implications for Molecular Subtyping.

Int J Gynecol Pathol 2020 Nov;39(6):514-521

Departments of Pathology and Laboratory Medicine, University of Saskatchewan, Saskatoon, Saskatchewan (N.B., J.D.C., M.K.) Department of Pathology and Laboratory Medicine, University of British Columbia and Vancouver General Hospital, Vancouver, British Columbia (C.B.G.), Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000638DOI Listing
November 2020

Precision medicine in endometrial cancer.

Gynecol Oncol 2019 09;154(3):451-453

Professor, Department of Pathology and Laboratory Science, University of British Columbia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.08.001DOI Listing
September 2019

Practical Guidance for Measuring and Reporting Surgical Margins in Vulvar Cancer.

Int J Gynecol Pathol 2020 Sep;39(5):420-427

Departments of Obstetrics and Gynecology (K.E.K., M.I.E.V.P.) Pathology (V.T.H.B.M.S., T.B.), Leiden University Medical Centre, Leiden, The Netherlands Department of Pathology, Ghent University Hospital, Gent (K.K.V.D.V.) Department of Pathology, University Hospitals Leuven, Leuven (A.S.V.R.), Belgium Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada (C.B.G.) Department of Cellular Pathology, Princess Alexandra Hospital, Harlow, Essex (S.A.) Department of Cellular Pathology, St. James's University Hospital, Leeds (D.A.) Department of Cellular Pathology, Barts Health NHS Trust, London (A.F., N.S.) Department of Cellular Pathology, University Hospitals Birmingham NHS Trust, Birmingham (R.G., B.T., J.V.) Department of Pathology, Airedale General Hospital, Keighley (N.R.G.) Department of Cellular Pathology, Stepping Hill Hospital, Stockport (R.H.) Department of Histopathology, Manor Hospital, Walsall Healthcare NHS Trust, Walsall (Y.L.H.) Department of Pathology, Belfast Health and Social Care Trust, Belfast (W.G.M.) Department of Cellular Pathology, Royal United Hospital, Bath (P.M.) Department of Pathology, Cambridge University Hospitals NHS Trust, Cambridge (B.R.) Department of Pathology, Royal Derby Hospital, Derby (G.V.S) Department of Histopathology, The Royal Sussex County Hospital, Brighton (M.V.), UK Division of Gynecologic, Breast & Perinatal Pathology, University Hospital Leipzig, Leipzig, Germany (L.C.H.) Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (K.J.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000631DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478209PMC
September 2020

Expression of L1 retrotransposon open reading frame protein 1 in gynecologic cancers.

Hum Pathol 2019 10 18;92:39-47. Epub 2019 Jun 18.

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V5Z 1L3, Canada; Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC V5Z 4E6, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2019.06.001DOI Listing
October 2019

Use of Immunohistochemical Markers (HNF-1β, Napsin A, ER, CTH, and ASS1) to Distinguish Endometrial Clear Cell Carcinoma From Its Morphologic Mimics Including Arias-Stella Reaction.

Int J Gynecol Pathol 2020 Jul;39(4):344-353

Department of Pathology and Laboratory Medicine, University of British Columbia (J.X.J., B.T.-C, B.G., D.G.H., L.N.H.) Department of Molecular Oncology, British Columbia Cancer Research Centre (D.R.C.) Genetic Pathology Evaluation Centre (S.L., A.S.C., C.C.) Department of Pathology, Vancouver General Hospital (B.G., L.N.H.), Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00004347-900000000-9910
Publisher Site
http://dx.doi.org/10.1097/PGP.0000000000000609DOI Listing
July 2020

Two versus four immunostains for Lynch syndrome screening in endometrial carcinoma.

Histopathology 2019 09 26;75(3):442-445. Epub 2019 Jul 26.

Department of Cellular Pathology, Barts Health NHS Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13898DOI Listing
September 2019

Molecular classification defines outcomes and opportunities in young women with endometrial carcinoma.

Gynecol Oncol 2019 06 25;153(3):487-495. Epub 2019 Mar 25.

Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.03.098DOI Listing
June 2019

Diagnostic Accuracy in Fit-for-Purpose PD-L1 Testing.

Appl Immunohistochem Mol Morphol 2019 04;27(4):251-257

Canadian Immunohistochemistry Quality Control.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00129039-900000000-9873
Publisher Site
http://dx.doi.org/10.1097/PAI.0000000000000734DOI Listing
April 2019

Synchronous carcinomas of endometrium and ovary: A pragmatic approach.

Gynecol Oncol Rep 2019 Feb 28;27:72-73. Epub 2018 Dec 28.

Dept of Cellular Pathology, BartsHealth NHS Trust, London, UK.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23525789183012
Publisher Site
http://dx.doi.org/10.1016/j.gore.2018.12.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354202PMC
February 2019

Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists.

Int J Gynecol Pathol 2019 Jan;38 Suppl 1:S64-S74

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York (R.A.S, K.J.P.) Department of Pathology, Stony Brook Hospital, SUNY, Stony Brook (C.T.), New York Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas (A.M.) Pathology Department, University Hospital Arnau de Vilanova and University Hospital of Bellvitge, Biomedical Research Institute, and Bellvitge Biomedical Institute, University of Lleida, CIBERONC, Spain (X.M.-G.) Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts (E.O.) Department of Pathology, Yale School of Medicine and the Yale School of Public Health, New Haven, Connecticut (V.P.) Department of Oncology-Pathology, Karolinska Institutet and Department of Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden (J.C.) Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK (W.G.M.) Department of Pathology and Laboratory Medicine, Vancouver General Hospital and University of British Columbia, Vancouver, BC, Canada (C.B.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000518DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295928PMC
January 2019

High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations.

Int J Gynecol Pathol 2019 Jan;38 Suppl 1:S40-S63

Department of Pathology, Memorial Sloan Kettering Cancer Center (R.M., R.A.S.) New York University Medical Center and School of Medicine, Tisch Hospital (K.M.), New York Department of Pathology, University Hospital, Stony Brook School of Medicine, Stony Brook (C.T.), New York Department of Pathology, Oslo University Hospital, Norwegian Radium Hospital; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway (B.D.) Department of Pathology, University of California San Diego, San Diego (O.F.) Department of Pathology, Cedars-Sinai Medical Center, Los Angeles (J.K.L.R.), California Department of Pathology, Karolinska Institutet, Stockholm, Sweden (J.A.C.) Department of Pathology, Brigham and Women's Hospital, Harvard Medical School (C.P.C.) Department of Pathology, Massachussetts General Hospital, Harvard Medical School (E.O.), Boston, Massachussetts Department of Pathology, University of British Columbia, Vancouver (C.B.G., J.A.I.) Department of Laboratory Medicine, Pathology and Medical Genetics, Royal Jubilee Hospital, Victoria (J.A.I.), BC, Canada Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas (A.M.) Department of Pathology, Hospital University Arnau de Vilanova; and Department of Pathology, Hospital University de Bellvitge, IRBLLEIDA, IDIBELL, University of Lleida, CIBERONC, Barcelona, Spain (X.M.-G.) Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK (W.G.M.) Department of Pathology and Obstetrics and Gynecology, Yale School of Medicine and Yale School of Publich Health, New Haven, Connecticut (V.P.) Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland (P.N.S.) Department of Pathology, KEMH and School for Women's and Infants' Health, University of Western Australia, Perth, WA, Australia (C.J.R.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000491DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296248PMC
January 2019

Issues in the Differential Diagnosis of Uterine Low-grade Endometrioid Carcinoma, Including Mixed Endometrial Carcinomas: Recommendations from the International Society of Gynecological Pathologists.

Int J Gynecol Pathol 2019 Jan;38 Suppl 1:S25-S39

Pathology Department, University of California San Francisco, San Francisco, California (J.T.R.) Department of Pathology and Laboratory Medicine, Vancouver General Hospital and University of British Columbia, Vancouver, British Columbia, Canada (C.B.G.) Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas (A.M.) Department of Pathology, University Hospital Arnau de Vilanova and Department of Pathology, University Hospital de Bellvitge, University of Lleida, IRBLLEIDA, IDIBELL, CIBERONC, Spain (X.M.G.) Department of Pathology, New York University Langone Medical Center, New York, New York (K.M.) Department of Pathology, Brigham and Women's Hospital (G.L.M.) Pathology Department, Massachusetts General Hospital (E.O.), Boston, Massachusetts Pathology Department, Yale New Haven Hospital, New Haven, Connecticut (V.P.) Department of Pathology, Johns Hopkins Medical Institutions (B.M.R.) Department of Pathology, University of Maryland School of Medicine (P.S.), Baltimore, Maryland Department of Histopathology, King Edward Memorial Hospital and School for Women's and Infants' Health, University of Western Australia, Perth, Australia (C.J.R.S.) Department of Pathology, Royal Group of Hospitals Trust, Belfast, Northern Ireland, UK (W.G.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000512DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296831PMC
January 2019

Molecular Subtype Not Immune Response Drives Outcomes in Endometrial Carcinoma.

Clin Cancer Res 2019 Apr 6;25(8):2537-2548. Epub 2018 Dec 6.

Departments of Gynecology and Obstetrics, and University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-3241DOI Listing
April 2019

Does MMR status in endometrial cancer influence response to adjuvant therapy?

Gynecol Oncol 2018 10 29;151(1):76-81. Epub 2018 Aug 29.

BC Cancer Agency, Vancouver, BC, Canada; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Vancouver, BC, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258183115
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2018.08.020DOI Listing
October 2018

A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract.

Am J Surg Pathol 2018 12;42(12):1596-1606

Department of Pathology and Laboratory Medicine, Vancouver General Hospital and University of British Columbia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000001142DOI Listing
December 2018

Histotype classification of ovarian carcinoma: A comparison of approaches.

Gynecol Oncol 2018 10 16;151(1):53-60. Epub 2018 Aug 16.

Huntsman Cancer Institute and Department of Population Health Sciences, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2018.08.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292681PMC
October 2018

Endometrial Cancer Presentation and Outcomes Based on Mismatch Repair Protein Expression From a Population-Based Study.

Int J Gynecol Cancer 2018 10;28(8):1624-1630

Department of Laboratory Medicine and Pathology, Lions Gate Hospital, North Vancouver.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000001343DOI Listing
October 2018

Tubo-Ovarian Transitional Cell Carcinoma and High-grade Serous Carcinoma Show Subtly Different Immunohistochemistry Profiles.

Int J Gynecol Pathol 2019 Nov;38(6):552-561

British Columbia Cancer Agency (J.M., A.N.K., A.T., D.C., D.G.H.) Department of Pathology, University of British Columbia (A.N.K., B.T.-C., C.C., A.C., C.B.G., D.G.H.), Vancouver, British Columbia, Canada Memorial Sloan Kettering Cancer Center, New York, New York (R.S.) Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands (S.H.) Department of Women's Health, Tübingen University Hospital, Tübingen (S.K.) Department of Gynecologic Oncology, Kliniken Essen Mitte, Essen (A.D.B.) Gynecologic Oncology Center, Kiel (J.P.) Institute of Pathology, Friedrichshafen (F.K.), Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000538DOI Listing
November 2019

Ovarian Carcinoma Histotype: Strengths and Limitations of Integrating Morphology With Immunohistochemical Predictions.

Int J Gynecol Pathol 2019 Jul;38(4):353-362

Departments of Pathology and Laboratory Medicine (M.K., S.L.) Community Health Sciences (L.S.C.), University of Calgary Department of Cancer Epidemiology and Prevention Research, Alberta Health Services-Cancer Control Alberta (X.G., L.S.C.), Calgary, Alberta Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver; and Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby (A.B.-W.) Department of Pathology and Laboratory Medicine, University of British Columbia (C.B.G.) Cancer Control Research, BC Cancer Research Centre (N.D.L.), Vancouver, British Columbia, Canada Department of Internal Medicine, Division of Epidemiology, Biostatistics and Preventive Medicine, UNM Comprehensive Cancer Center, University of New Mexico, Albuquerque, New Mexico (L.L., L.S.C.).

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00004347-900000000-9918
Publisher Site
http://dx.doi.org/10.1097/PGP.0000000000000530DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291360PMC
July 2019

Artefactual punctate MLH1 staining can lead to erroneous reporting of isolated PMS2 loss.

Histopathology 2018 10 12;73(4):703-705. Epub 2018 Jul 12.

Department of Cellular Pathology Barts Health NHS Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13663DOI Listing
October 2018

DICER1 hot-spot mutations in ovarian gynandroblastoma.

Histopathology 2018 Aug 5;73(2):306-313. Epub 2018 Jun 5.

Institute of Pathology, Medizin Campus Bodensee, Friedrichshafen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13630DOI Listing
August 2018

Interpretation of P53 Immunohistochemistry in Endometrial Carcinomas: Toward Increased Reproducibility.

Int J Gynecol Pathol 2019 Jan;38 Suppl 1:S123-S131

Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta (M.K.) Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia (C.B.G.), Canada Department of Pathology and Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, Maryland (B.M.R.) Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (R.A.S.) Department of Cellular Pathology, Barts Health NHS Trust, London (N.S.) Department of Pathology, Belfast Health and Social Care Trust, Belfast (W.G.M.), UK.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00004347-900000000-9921
Publisher Site
http://dx.doi.org/10.1097/PGP.0000000000000488DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127005PMC
January 2019

MyD88 and TLR4 Expression in Epithelial Ovarian Cancer.

Mayo Clin Proc 2018 03;93(3):307-320

Department of Health Sciences Research, Mayo Clinic, Rochester, MN. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2017.10.023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870793PMC
March 2018

Bartholin Gland Carcinoma: Clinicopathologic Features, Including p16 Expression and Clinical Outcome.

Int J Gynecol Pathol 2019 Mar;38(2):189-195

Department of Pathology and Laboratory Medicine (T.N., A.S.C., A.N.K., C.B.G.) Genetic Pathology Evaluation Centre (A.S.C.), University of British Columbia Division of Anatomical Pathology, Vancouver General Hospital (T.N., A.N.K., C.B.G.) Division of Medical Oncology, British Columbia Cancer Agency (A.T.), Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00004347-900000000-9922
Publisher Site
http://dx.doi.org/10.1097/PGP.0000000000000489DOI Listing
March 2019

Canadian Consensus-based and Evidence-based Guidelines for Benign Endometrial Pathology Reporting in Biopsy Material.

Int J Gynecol Pathol 2019 Mar;38(2):119-127

Department of Laboratory Medicine and Pathobiology, University of Toronto and Sunnybrook Health Sciences Centre (C.P.-H., M.C., B.D.) Department of Laboratory Medicine and Pathobiology, University of Toronto and Trillium Health Partners (A.P.), Toronto, ON Department of Pathology, University Hospital of Quebec (Centre Hospitalier Universitaire de Quebec), Quebec, QC (K.G.) Department of Pathology and Laboratory Medicine, University of Saskatchewan and Saskatoon City Hospital, Saskatoon, SK (M.K.) Department of Pathology and Laboratory Medicine, University of Calgary and Arnie Charbonneau Cancer Institute, Calgary, AB (M.K.) Department of Laboratory Medicine, Memorial University, St John's, NL (A.P.) Department of Pathology, University of British Columbia and Vancouver General Hospital, Vancouver, BC, Canada (C.B.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000481DOI Listing
March 2019

Case report: an identical twin with Sertoli-Leydig cell tumor.

Gynecol Endocrinol 2018 Jul 24;34(7):563-566. Epub 2018 Jan 24.

a Department of Obstetrics and Gynaecology, Division of Reproductive Endocrinology and Infertility , University of British Columbia , Vancouver , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/09513590.2018.1431215DOI Listing
July 2018

Hematoxylin and Eosin Counterstaining Protocol for Immunohistochemistry Interpretation and Diagnosis.

Appl Immunohistochem Mol Morphol 2019 08;27(7):558-563

Centre de recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0000000000000626DOI Listing
August 2019

Synchronous tumours of the female reproductive tract.

Pathology 2018 Feb 14;50(2):214-221. Epub 2017 Dec 14.

Institute of Pathology, Friedrichshafen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pathol.2017.10.007DOI Listing
February 2018

The evolution of endometrial carcinoma classification through application of immunohistochemistry and molecular diagnostics: past, present and future.

Virchows Arch 2018 Jun 12;472(6):885-896. Epub 2017 Dec 12.

Department of Anatomic Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00428-017-2279-8
Publisher Site
http://dx.doi.org/10.1007/s00428-017-2279-8DOI Listing
June 2018

Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

Authors:
Ellen L Goode Matthew S Block Kimberly R Kalli Robert A Vierkant Wenqian Chen Zachary C Fogarty Aleksandra Gentry-Maharaj Aleksandra Tołoczko Alexander Hein Aliecia L Bouligny Allan Jensen Ana Osorio Andreas Hartkopf Andy Ryan Anita Chudecka-Głaz Anthony M Magliocco Arndt Hartmann Audrey Y Jung Bo Gao Brenda Y Hernandez Brooke L Fridley Bryan M McCauley Catherine J Kennedy Chen Wang Chloe Karpinskyj Christiani B de Sousa Daniel G Tiezzi David L Wachter Esther Herpel Florin Andrei Taran Francesmary Modugno Gregg Nelson Jan Lubiński Janusz Menkiszak Jennifer Alsop Jenny Lester Jesús García-Donas Jill Nation Jillian Hung José Palacios Joseph H Rothstein Joseph L Kelley Jurandyr M de Andrade Luis Robles-Díaz Maria P Intermaggio Martin Widschwendter Matthias W Beckmann Matthias Ruebner Mercedes Jimenez-Linan Naveena Singh Oleg Oszurek Paul R Harnett Peter F Rambau Peter Sinn Philipp Wagner Prafull Ghatage Raghwa Sharma Robert P Edwards Roberta B Ness Sandra Orsulic Sara Y Brucker Sharon E Johnatty Teri A Longacre Eilber Ursula Valerie McGuire Weiva Sieh Yanina Natanzon Zheng Li Alice S Whittemore deFazio Anna Annette Staebler Beth Y Karlan Blake Gilks David D Bowtell Estrid Høgdall Francisco J Candido dos Reis Helen Steed Ian G Campbell Jacek Gronwald Javier Benítez Jennifer M Koziak Jenny Chang-Claude Kirsten B Moysich Linda E Kelemen Linda S Cook Marc T Goodman María José García Peter A Fasching Stefan Kommoss Suha Deen Susanne K Kjaer Usha Menon James D Brenton Paul DP Pharoah Georgia Chenevix-Trench David G Huntsman Stacey J Winham Martin Köbel Susan J Ramus

JAMA Oncol 2017 12;3(12):e173290

School of Women’s and Children’s Health, University of New South Wales, Sydney, Australia

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2017.3290DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744673PMC
December 2017

Pathology of Ovarian Cancer: Recent Insights Unveiling Opportunities in Prevention.

Clin Obstet Gynecol 2017 12;60(4):686-696

Department of Pathology and Laboratory Medicine, Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/GRF.0000000000000314DOI Listing
December 2017

Survival Benefit of Adjuvant Radiotherapy: An Analysis of Low-Stage Invasive Ovarian Mucinous Carcinomas.

Int J Gynecol Cancer 2017 11;27(9):1819-1825

*BC Cancer Agency, Surrey Clinic, Surrey; and †Cancer Control, British Columbia Cancer Research Centre; ‡Cheryl Brown Ovarian Cancer Outcomes Unit, OvCaRe; §Vancouver General Hospital and University of British Columbia; and ∥BC Cancer Agency, Vancouver Clinic, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000001124DOI Listing
November 2017

Hereditary Breast and Ovarian Cancer Syndrome: Moving Beyond BRCA1 and BRCA2.

Adv Anat Pathol 2018 Mar;25(2):85-95

Department of Pathology and Laboratory Medicine, Vancouver General Hospital and University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAP.0000000000000177DOI Listing
March 2018

Disease Distribution in Low-stage Tubo-ovarian High-grade Serous Carcinoma (HGSC): Implications for Assigning Primary Site and FIGO Stage.

Int J Gynecol Pathol 2018 Jul;37(4):324-330

Departments of Cellular Pathology (N.S., J.L.B., A.Z.F., G.T., S.L.S.L.) Gynaecological Oncology (C.G.), Barts Health NHS Trust Department of Pathology, University College Hospital NHS Trust (R.A.), London Department of Cellular Pathology, Birmingham Women's NHS Foundation Trust, Birmingham (L.H.) Department of Pathology, Belfast Health and Social Care Trust, Belfast, Northern Ireland (K.S., W.G.M.) St James's Hospital, Leeds (N.W.), UK British Columbia Cancer Agency (M.A., F.K.) Department of Pathology and Laboratory Medicine, University of British Columbia (C.B.G.), Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000429DOI Listing
July 2018

Identical TP53 mutations provide evidence that late-recurring tubo-ovarian high-grade serous carcinomas do not represent new peritoneal primaries.

Histopathology 2017 12 22;71(6):1014-1017. Epub 2017 Sep 22.

Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13327DOI Listing
December 2017

Cancer-Associated Mutations in Endometriosis without Cancer.

N Engl J Med 2017 05;376(19):1835-1848

From the Departments of Obstetrics and Gynaecology (M.S.A., C.A., C.W., P.J.Y., D.G.H.) and Pathology and Laboratory Medicine (M.S.A., T.M.N., J. Senz, B.T.-C., C.B.G., D.G.H.), University of British Columbia, the Department of Anatomical Pathology, Vancouver General Hospital (T.M.N., H.M.H., J.H., V.L., B.T.-C., A.W., C.B.G., D.G.H.), the Department of Molecular Oncology, British Columbia Cancer Agency (H.M.H., A.L., V.L., N.B., D.G.H.), and the BC Women's Centre for Pelvic Pain and Endometriosis, BC Women's Hospital and Health Centre (F.W., N.O., C.A., C.W., P.J.Y.) - all in Vancouver, BC, Canada; the Department of Oncology (N.P., C.T., K.W.K., L.D., T.-L.W., B.V., I.-M.S.) and Ludwig Center (N.P., Y.W., J.D.C., M.Z., M.P., W.M., A.M., K.W.K., L.D., B.V.), Sidney Kimmel Comprehensive Cancer Center, the Departments of Pathology (N.P., A.A., M.N., L.D.W., T.-L.W., B.V., I.-M.S.) and Gynecology and Obstetrics (J. Segars, I.-M.S.), Johns Hopkins Medical Institutions, Personal Genome Diagnostics (S.J.), and Johns Hopkins University Howard Hughes Medical Institute (B.V.) - all in Baltimore; the Department of Pathology, Seirei Mikatahara Hospital (A.A., H.O.), and the Department of Tumor Pathology, Hamamatsu University School of Medicine (A.A.), Hamamatsu, and the Department of Molecular Pathology, Hiroshima University School of Medicine, Hiroshima (A.A.) - all in Japan; the Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands (M.N.); the Departments of Obstetrics and Gynecology (T.S.) and Pathology (R.A., A.H.), Lenox Hill Hospital-Northwell Health (Hofstra University), New York; and the Department of Pathology, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Tao-Yuan City, Taiwan (R.-C.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1614814DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555376PMC
May 2017

High-grade serous carcinoma of tubo-ovarian origin: recent developments.

Histopathology 2017 Sep 18;71(3):339-356. Epub 2017 Jul 18.

Department of Anatomic Pathology, Vancouver General Hospital, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13248DOI Listing
September 2017

Molecular subtyping of mammary-like adenocarcinoma of the vulva shows molecular similarity to breast carcinomas.

Histopathology 2017 Sep 16;71(3):446-452. Epub 2017 Jun 16.

Division of Anatomical Pathology, Vancouver General Hospital, University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13239DOI Listing
September 2017

HPV-independent Differentiated Vulvar Intraepithelial Neoplasia (dVIN) is Associated With an Aggressive Clinical Course.

Int J Gynecol Pathol 2017 Nov;36(6):507-516

Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, University of British Columbia (J.N.M., S.Y.K., D.M.M.) Department of Pathology and Laboratory Medicine, University of British Columbia and BC Cancer Agency (A.A., S.E., C.B.G.) Vancouver, BC, Canada Department of Applied Tumor Biology, Institute of Pathology, University of Heidelberg, and Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany (M.R., M.v.K.D., E.S.P.) Department of Cellular Pathology, Barts and the London NHS Trust, London, UK (S.J., N.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000375DOI Listing
November 2017

Ovarian carcinoma histotype in Lynch syndrome.

Gynecol Oncol Rep 2017 May 16;20:140-141. Epub 2017 Mar 16.

Dept of Human Genetics, McGill University, Montreal, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gore.2017.03.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993521PMC
May 2017

Human papillomavirus (HPV)-independent vulvar squamous cell carcinoma has a worse prognosis than HPV-associated disease: a retrospective cohort study.

Histopathology 2017 Aug 23;71(2):238-246. Epub 2017 May 23.

Department of Pathology and Laboratory Medicine, University of British Columbia and BC Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13205DOI Listing
August 2017

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine. Part 3: Technical Validation of Immunohistochemistry (IHC) Assays in Clinical IHC Laboratories.

Appl Immunohistochem Mol Morphol 2017 03;25(3):151-159

*Department of Laboratory Medicine and Pathobiology, University of Toronto Departments of †Laboratory Hematology §Pathology, University Health Network, Toronto, ON ∥∥Vancouver General Hospital, University of British Columbia, Vancouver, BC ¶¶¶Department of Pathology and Laboratory Medicine, Cumming School of Medicine University of Calgary, and Calgary Laboratory Services, Calgary, AB, Canada ‡Canadian Immunohistochemistry Quality Control (CIQC), Vancouver, BC, Canada/Canadian Association of Pathologists National Standards Committee for High Complexity Testing/Immunohistochemistry ∥Poundbury Cancer Institute ¶Dorset County Hospital NHS Foundation Trust, Dorchester, UK #Cancer Diagnostic Quality Assurance Services (CADQAScic), Dorchester ***UK National External Quality Assessment Scheme (UK NEQAS), University College London, London, UK **School of Medicine, Institute of Pathology, Charité-University Hospital, Berlin, Berlin, Germany ††Griffith University, Gold Coast ‡‡RCPA Quality Assurance Program, Sydney §§Genomics For Life, Brisbane, Australia ¶¶International Quality Network for Pathology (IQN Path), Luxembourg City, Luxembourg ##Brigham and Women's Hospital, Harvard Medical School, Boston, MA †††Center of Predictive Molecular Medicine, Center for Excellence on Ageing and Translational Medicine, University of Chieti-Pescara, Chieti, Italy ‡‡‡Department of Pathology, Radboud University Medical Centre, Nijmegen, The Netherlands §§§Institute of Pathology, and Department of Clinical Medicine, Aalborg University, Aalborg University Hospital ∥∥∥Nordic Immunohistochemistry Quality Control (NordiQC), Aalborg, Denmark ###Department of Pathology, Beijing Friendship Hospital, Capital Medical University, Beijing ****Chinese Committee for Pathologists-Immunohistochemistry Quality Control, China ††††Keck School of Medicine, University of Southern California, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0000000000000470DOI Listing
March 2017

Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance Characteristics.

Appl Immunohistochem Mol Morphol 2017 02;25(2):79-85

*Department of Laboratory Medicine and Pathobiology, University of Toronto, Vancouver, BC, CanadaDepartment of †Laboratory Hematology§Pathology, University Health Network, Toronto, ON, Canada‡Canadian Immunohistochemistry Quality Control (CIQC)/Canadian Association of Pathologists National Standards Committee for High Complexit Testing/Immunohistochemistry∥Poundbury Cancer Institute¶Dorset County Hospital NHS Foundation Trust#Cancer Diagnostic Quality Assurance Services (CADQAScic), Dorchester, UK***UK National External Quality Assessment Scheme (UK NEQAS), University College London, London, UK**"Rudolf-Virchow-Haus", Institute of Pathology, Charité-University Hospital Berlin, Berlin, Germany††School of Medicine, Griffith University, Gold Coast‡‡Genomics For Life, Brisbane, QLD§§RCPA Quality Assurance Program, Sydney, NSW, Australia∥∥Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada¶¶International Quality Network for Pathology (IQN Path), Luxembourg City, Luxembourg, and Division of Cancer, Department of Surgery & Cancer, Imperial College London, UK##Brigham and Women's Hospital, Harvard Medical School, Boston, MA†††Center of Predictive Molecular Medicine, Center for Excellence on Ageing and Translational Medicine, University of Chieti-Pescara, Chieti, Italy‡‡‡Department of Pathology, Radboud University Medical Centre, Nijmegen, The Netherlands§§§Institute of Pathology, Aalborg University Hospital and Department of Clinical Medicine, Aalborg University, Denmark∥∥∥Nordic Immunohistochemistry Quality Control (NordiQC), Aalborg, Denmark¶¶¶Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary and Calgary Laboratory Services, Calgary, AB###Department of Pathology, Beijing Friendship Hospital, Capital Medical University****CCP-IHCQC, Chinese Committee for Pathologists-Immunohistochemistry Quality Control, Beijing, China††††Keck School of Medicine, University of Southern California, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0000000000000444DOI Listing
February 2017